ENDRA Life Sciences Balance Sheet (2016-2025) | NDRA

Balance Sheet Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Assets
Current Assets
Cash & Equivalents (Quarter)
16.84M14.04M11.79M9.46M7.13M11.28M8.02M4.89M2.36M4.82M3.33M2.83M1.13M6.40M4.75M3.23M2.06M1.81M0.79M0.76M
Cash & Current Investments (Quarter)
16.84M14.04M11.79M9.46M7.13M11.28M8.02M4.89M2.36M4.82M3.33M2.83M1.13M6.40M4.75M3.23M2.06M1.81M0.79M0.76M
Receivables - Net (Quarter)
Receivables (Quarter)
Inventory (Quarter)
0.73M1.32M1.50M1.28M1.93M2.37M2.63M2.64M2.74M2.76M2.76M2.62M2.71M2.71M2.71M
Prepaid Assets (Quarter)
0.78M0.97M1.18M1.35M1.06M0.83M0.91M0.49M0.43M0.51M0.31M0.20M0.14M0.31M0.22M0.20M0.12M0.04M0.25M0.21M
Current Assets (Quarter)
18.35M16.34M14.47M12.09M10.12M14.49M11.56M5.38M5.52M8.08M6.40M3.03M1.27M6.71M4.96M3.43M2.18M1.85M1.05M0.97M
Non-Current Assets
Construction in Progress (Quarter)
0.11M0.11M0.14M0.14M0.14M0.14M0.14M0.14M0.13M0.13M0.13M0.13M
Property, Plant & Equipment (Net) (Quarter)
0.23M0.19M0.16M0.13M0.20M0.24M0.23M0.24M0.23M0.19M0.16M0.11M0.11M0.09M0.08M0.07M0.06M0.06M0.05M0.04M
Long-Term Deferred Tax (Quarter)
13.83M21.16M24.57M
Other Non-Current Assets (Quarter)
0.01M0.01M0.01M0.01M0.01M0.50M0.01M0.01M0.01M0.01M0.65M0.65M0.01M0.37M0.01M0.01M0.01M0.01M
Non-Current Assets (Quarter)
0.55M0.90M0.84M0.78M0.82M0.82M0.78M3.89M1.14M1.16M1.20M3.72M3.79M3.73M3.42M1.02M0.99M0.95M0.92M2.89M
Assets (Quarter)
18.90M17.24M15.31M12.87M10.94M15.31M12.34M9.27M6.65M9.24M7.60M6.75M5.06M10.44M8.38M4.45M3.17M2.81M1.96M3.85M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
1.51M1.51M1.45M1.41M1.22M1.36M1.56M1.52M1.65M1.84M1.97M0.70M1.04M1.17M0.63M0.51M0.44M0.45M0.67M0.62M
Notes Payables (Quarter)
0.03M0.03M0.03M0.03M
Payables (Quarter)
1.51M1.51M1.45M1.41M1.22M1.36M1.56M1.55M1.65M1.87M2.00M0.73M1.04M1.17M0.63M0.51M0.44M0.45M0.67M0.62M
Accumulated Expenses (Quarter)
0.21M0.20M0.10M0.15M0.21M0.16M0.06M0.22M0.20M0.27M0.15M0.27M0.33M0.13M0.06M0.12M0.11M
Short term Debt (Quarter)
0.03M0.03M0.03M0.03M
Current Leases (Quarter)
0.08M0.12M0.13M0.13M0.14M0.14M0.15M0.15M0.16M0.16M0.17M0.17M0.18M0.18M0.19M0.10M0.13M0.13M0.13M0.13M
Current Deferred Revenue (Quarter)
0.91M0.80M0.39M0.33M
Total Current Liabilities (Quarter)
0.77M1.64M1.58M1.54M1.36M1.50M1.71M1.70M1.83M2.03M2.17M0.90M1.22M1.35M0.81M0.61M0.57M0.58M0.80M0.75M
Non-Current Liabilities
Non-Current Debt (Quarter)
0.03M0.03M0.58M0.03M0.03M0.03M0.03M0.03M
Convertible Debt (Quarter)
Operating Leases (Quarter)
0.33M0.71M0.68M0.65M0.62M0.59M0.55M0.52M0.48M0.44M0.41M0.19M0.15M0.10M0.05M0.49M0.59M0.43M0.53M0.36M
Other Non-Current Liabilities (Quarter)
0.80M0.60M0.48M
Total Non-Current Liabilities (Quarter)
0.28M0.37M0.24M0.19M0.15M0.10M0.96M1.29M0.85M0.76M0.99M0.84M
Total Liabilities (Quarter)
1.05M2.25M2.16M2.09M1.87M1.98M2.14M2.07M2.16M2.31M2.41M1.10M1.36M1.45M1.77M1.89M1.42M1.33M1.79M1.59M
Shareholder's Equity
Total Debt (Quarter)
0.03M0.03M0.58M0.03M0.03M0.03M0.03M0.06M0.03M0.03M0.03M
Common Equity (Quarter)
17.85M14.99M13.16M10.78M9.07M13.33M10.20M7.20M4.50M6.93M5.20M5.66M3.70M8.99M6.60M2.56M1.75M1.47M0.17M2.26M
Shareholder's Equity (Quarter)
17.85M14.99M13.16M10.78M9.07M13.33M10.20M7.20M4.50M6.93M5.20M5.66M3.70M8.99M6.60M2.56M1.75M1.47M0.17M2.26M
Liabilities and Shareholders Equity (Quarter)
18.90M17.24M15.31M12.87M10.94M15.31M12.34M9.27M6.65M9.24M7.60M6.75M5.06M10.44M8.38M4.45M3.17M2.81M1.96M3.85M
Retained Earnings (Quarter)
-59.73M-62.93M-65.59M-68.69M-71.55M-75.14M-78.58M-81.87M-84.81M-87.37M-90.47M-91.93M-94.71M-96.94M-99.29M-103.44M-104.47M-105.70M-107.30M-110.47M
Preferred Shares (Quarter)
1.001.001.001.001.001.00
Treasury Shares (Quarter)
2.44M2.44M0.12M2.44M